Maria Palasis - 16 Oct 2024 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
President & CEO, Director
Signature
/s/ Jason Cavalier, Attorney-in-Fact for Maria Palasis
Issuer symbol
LYRA
Transactions as of
16 Oct 2024
Net transactions value
$0
Form type
4
Filing time
18 Oct 2024, 16:05:06 UTC
Previous filing
20 Mar 2024
Next filing
11 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LYRA Common Stock Award $0 +300,000 $0.000000 300,000 16 Oct 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in three substantially equal installments occurring on April 1, 2025, October 1, 2025 and April 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.